| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Repare Therapeutics Inc. (RPTX) has 6 insiders with recent SEC Form 4 filings, including 0 buys and 32 sells. RPTX is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 0 | - | - | |
| VP | 0 | - | - | |
| Dir | 0 | - | - | |
| CFO | 0 | - | - | |
| Dir | 0 | - | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jul 12, 2021 | Foley Todd82 | Director | Sell | 27,351 | $33.55 | $917,677.50 | -0.4% | -42.1% | -55.5% | |
| Jun 29, 2021 | Gadicke Ansbert85 | 10% Owner | Sell | 19,200 | $34.06 | $653,925.00 | -0.2% | -17.1% | -58.6% | |
| Jun 29, 2021 | Foley Todd82 | Director | Sell | 8,460 | $34.06 | $288,135.70 | -0.1% | -17.1% | -58.6% | |
| Jun 28, 2021 | Segal Lloyd Mitchell85 | President And CEO | Sell | 1,542 | $35.61 | $54,910.62 | -1.6% | -19.5% | -59.5% | |
| Jun 25, 2021 | Foley Todd82 | Director | Sell | 12,640 | $33.51 | $423,620.34 | -0.3% | -14.1% | -55.7% | |
| Jun 25, 2021 | Gadicke Ansbert85 | 10% Owner | Sell | 28,688 | $33.51 | $961,457.30 | -0.4% | -14.1% | -55.7% | |
| Jun 23, 2021 | Gadicke Ansbert85 | 10% Owner | Sell | 42,798 | $34.36 | $1,470,441.41 | -0.2% | -12.5% | -55.6% | |
| Jun 23, 2021 | Foley Todd82 | Director | Sell | 18,859 | $34.36 | $647,950.11 | -0.2% | -12.5% | -55.6% | |
| Jun 18, 2021 | Foley Todd82 | Director | Sell | 18,294 | $33.77 | $617,761.92 | -0.2% | -9.9% | -61.0% | |
| Jun 18, 2021 | Gadicke Ansbert85 | 10% Owner | Sell | 41,518 | $33.77 | $1,402,002.19 | -0.3% | -9.9% | -61.0% |